Failure-Free Protection & Performance

Ensuring Mission Performance & Aircrew Protection for FLRAA & Enduring Fleet
Document image: GORE Protein Capture Device for Early Clinical Applications, 9.0mL (PROA103) - Operating Instructions

General handling, antibody purification protocol and troubleshooting guide for PROA103.

GORE Protein Capture Device for Early Clinical Applications, 9.0mL (PROA103)

This unique membrane Device offered in 9.0 mL has a capacity of ≥ 360 mg when using 1.25 mg/mL human polyclonal hIgG in phosphate-buffered solution at 30 seconds residence time (SRT).  Request the Validation Guide for complete testing details.

This document is available upon request.

DATASHEET:  GORE Protein Capture Device for Early Clinical Applications

The 9.0mL Device (PROA103) GORE Protein Capture Device provides performance advantages over traditional agarose resin columns in late stage discovery, pre-clinical and early clinical applications.

Application Note:  Increase productivity with a simulated moving bed chromatography technique.

Evaluate the GORE® Protein Capture Device with Protein A combined with a simulated moving bed chromatography technique, CaptureSMB(TM), to increase the productivity of IgG purification. A joint study with Athena Enzyme Systems and Gore & Associates.

Subscribe to Content
Top